JD Health International Inc.

6618

KYG5074A1004

JD Health International Inc is a China-based investment holding company principally engaged in the Internet + Healthcare ecosystem business. The Company mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The Company mainly conducts its businesses in domestic market.

Sector

Drug Retailers

Calendar

2024-08-19 - Q2 2024 Earnings Release (Projected)

Related indices

HONG KONG HANG SENG

More about the company

Income Statement Evolution

More financial data

Ratings for JD Health International Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

21.35 CNY

Average target price

40.01 CNY

Spread / Average Target

+87.39%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
JD HEALTH INTERNATIONAL INC.	-39.64%	9.41B
WALGREENS BOOTS ALLIANCE, INC.	-32.48%	15.21B
MATSUKIYOCOCOKARA & CO.	-8.23%	6.23B
YIFENG PHARMACY CHAIN CO., LTD.	+5.64%	5.91B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-36.32%	5.42B
NAHDI MEDICAL COMPANY	+2.92%	4.89B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+49.84%	4.27B
CLICKS GROUP LIMITED	-14.64%	3.51B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-12.53%	3.43B
WELCIA HOLDINGS CO., LTD.	-6.83%	3.08B

Other Drug Retailers

Delayed Hong Kong S.E. Other stock markets 11:59:39 2024-04-17 pm EDT			5-day change	1st Jan Change
23.6 ^HKD	+2.16%		-8.70%	-39.64%

Apr. 11	China stocks rise as commodities shine; Hong Kong snaps winning streak	RE
Apr. 03	Alibaba Health Refutes Rumors of Purchase of Telemedicine Platform HaoDF	MT

China stocks rise as commodities shine; Hong Kong snaps winning streak	Apr. 11	RE
Alibaba Health Refutes Rumors of Purchase of Telemedicine Platform HaoDF	Apr. 03	MT
Nomura Adjusts JD Health’s Price Target to HK$44 to HK$37, Keeps at Buy	Mar. 22	MT
China stocks fall on weaker yuan, outflows	Mar. 22	RE
Transcript : JD Health International Inc., 2023 Earnings Call, Mar 21, 2024	Mar. 20
JD Health's 2023 Profit Soars Almost Sixfold to Over 2 Billion Yuan	Mar. 20	MT
JD Health International Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Central Bank Outlooks Lift Asian Stock Markets	Mar. 18	MT
Beijing Outlook Blunts Asian Stock Markets	Mar. 05	MT
China Outlook, Tech Rally Roils Asian Stock Markets	Jan. 19	MT
Nomura Adjusts JD Health International’s Price Target to HK$44 from HK$60, Keeps at Buy	Jan. 19	MT
China Economic Outlook Curbs Asian Stock Markets	Jan. 16	MT
Wall Street Cues Undercut Asian Stock Markets	Jan. 03	MT
China Trade Outlook, Moody's Downgrade Undercut Asian Stock Markets	Dec. 07	MT
JD Health Reallocates IPO Funds Saved for R&D to Business Expansion; Shares Drop 7%	Nov. 29	MT
JD Health's Operating Profit Soars 126% in Q3	Nov. 15	MT
China Proposes Easing of Cross-Border Data Controls -- Update	23-09-29	DJ
China Property Woes Undercut Asian Stock Markets	23-08-18	MT
Nomura Adjusts JD Health's Price Target to HK$60 From HK$75, Keeps at Buy	23-08-18	MT
JD Health's Profit Skyrockets 600.6% in H1; Shares Slump 7%	23-08-17	MT
JD Health International Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-16	CI
Central Bank Outlooks Lift Asian Stock Markets	23-06-12	MT
JD Health International to Launch Dual Counter Program	23-06-07	MT
JD Health International Inc.(SEHK:6618) added to Hang Seng Index	23-06-05	CI
JD Health Applies for RMB Counter in Hong Kong	23-05-19	MT